Slideshows Images Quizzes

Anturane

Last reviewed on RxList: 12/8/2004
Anturane Side Effects Center

Last reviewed on RxList 3/18/2016

Anturane (sulfinpyrazone) is an auricosuric agent used to treat gout and gouty arthritis. The brand name Anturane is discontinued, but generic versions may be available. Common side effects of Anturane (sulfinpyrazone) include:

The initial dose of Anturane is 200-400 mg daily in two divided doses, with meals or milk, gradually increasing when necessary to full maintenance dosage in one week. Anturane may interact with aspirin and other salicylates, acetaminophen (Tylenol), warfarin, tolbutamide, theophylline, verapamil, and niacin. Tell your doctor all medications and supplements you use. It is unknown if Anturane will harm a fetus. Tell your doctor if you are pregnant before taking Anturane. It is also unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Anturane (sulfinpyrazone) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Anturane Professional Information

SIDE EFFECTS

The most frequently reported adverse reactions with Anturane (sulfinpyrazone) have been upper gastrointestinal disturbances. In these patients it is advisable to administer the drug with food, milk, or antacids. Despite this precaution, Anturane (sulfinpyrazone) may aggravate or reactivate peptic ulcer.

Rash has been reported. In most instances, this reaction did not necessitate discontinuance of therapy. In general, Anturane (sulfinpyrazone) has not been observed to affect electrolyte balance.

Blood dyscrasias (anemia, leukopenia, agranulocytosis, thrombocytopenia, and aplastic anemia) have rarely been reported. There has also been a published report associating Anturane (sulfinpyrazone) , administered concomitantly with other drugs including colchicine, with leukemia following long term treatment of patients with gout. However, the circumstances involved in the two cases reported are such that a cause-and-effect relationship to Anturane (sulfinpyrazone) has not been clearly established.

Read the entire FDA prescribing information for Anturane (Sulfinpyrazone)

Related Resources for Anturane

Related Health

© Anturane Patient Information is supplied by Cerner Multum, Inc. and Anturane Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors